R-GDP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-GDP, covering 2017-12-14 to 2017-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]